Celgene has said it will fight to ensure patients get access to its blood cancer drug Vidaza (azacitadine) following its rejection by NICE, saying that mistakes by both organisations led to a huge ...

An observational study recently published in Cancer highlights a notable correlation between glucose-6-phosphate dehydrogenase (G6PD) deficiency and improved clinical outcomes among patients with ...

Servier is already in the process of transforming itself into a much bigger player in cancer, and has just tripled its sales objectives for the category. Fresh with a new brand identity, the ...

Paul Marks, aged 83, spends his weekdays in a tidy, sunlit office on New York's Upper East Side. From there he can keep a close watch on his lab, housed in one of Memorial Sloan-Kettering Cancer ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices are ...

Cell death is a normal facet of human physiology, ensuring tissue homeostasis by offsetting cell production with cell demise. Neoplasms arise in part because of defects in physiological cell death ...

Myelodysplastic syndromes (MDS) cause atypical bone marrow cells and low blood counts. This can lead to fatigue, shortness of breath, infections, bruising, and bleeding. Myelodysplastic syndromes (MDS ...